

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.62358708 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62358708 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.56945290 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.56945290 |
| 5 | paraxial mesoderm development (GO:0048339) | 4.40397247 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.36485863 |
| 7 | protein carboxylation (GO:0018214) | 4.27494548 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.27494548 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 4.14443990 |
| 10 | glyoxylate metabolic process (GO:0046487) | 3.97145173 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 3.94881455 |
| 12 | regulation of protein activation cascade (GO:2000257) | 3.90015210 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 3.89833749 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.82491765 |
| 15 | regulation of fibrinolysis (GO:0051917) | 3.78873746 |
| 16 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.73022303 |
| 17 | regulation of complement activation (GO:0030449) | 3.70356051 |
| 18 | urea metabolic process (GO:0019627) | 3.63696912 |
| 19 | urea cycle (GO:0000050) | 3.63696912 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.56006374 |
| 21 | complement activation, alternative pathway (GO:0006957) | 3.54602532 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 3.50050838 |
| 23 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.48451902 |
| 24 | bile acid biosynthetic process (GO:0006699) | 3.47486931 |
| 25 | kynurenine metabolic process (GO:0070189) | 3.46715765 |
| 26 | cellular modified amino acid catabolic process (GO:0042219) | 3.42108478 |
| 27 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.41003818 |
| 28 | triglyceride homeostasis (GO:0070328) | 3.33523847 |
| 29 | acylglycerol homeostasis (GO:0055090) | 3.33523847 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 3.31935470 |
| 31 | tryptophan catabolic process (GO:0006569) | 3.31935470 |
| 32 | indole-containing compound catabolic process (GO:0042436) | 3.31935470 |
| 33 | lysine metabolic process (GO:0006553) | 3.26929219 |
| 34 | lysine catabolic process (GO:0006554) | 3.26929219 |
| 35 | coenzyme catabolic process (GO:0009109) | 3.21766691 |
| 36 | homocysteine metabolic process (GO:0050667) | 3.15537273 |
| 37 | bile acid metabolic process (GO:0008206) | 3.14347776 |
| 38 | cysteine metabolic process (GO:0006534) | 3.10495351 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 3.08540086 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 3.08287561 |
| 41 | regulation of plasminogen activation (GO:0010755) | 3.07491173 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 3.07320762 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 3.07209415 |
| 44 | collagen fibril organization (GO:0030199) | 3.06629361 |
| 45 | tryptophan metabolic process (GO:0006568) | 3.06376742 |
| 46 | regulation of cholesterol homeostasis (GO:2000188) | 3.03347038 |
| 47 | convergent extension (GO:0060026) | 3.03292265 |
| 48 | negative regulation of sterol transport (GO:0032372) | 3.02177893 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 3.02177893 |
| 50 | bile acid and bile salt transport (GO:0015721) | 3.02162628 |
| 51 | acetyl-CoA metabolic process (GO:0006084) | 3.01280065 |
| 52 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.00707728 |
| 53 | fatty acid beta-oxidation (GO:0006635) | 2.99806509 |
| 54 | notochord development (GO:0030903) | 2.97788847 |
| 55 | bone trabecula formation (GO:0060346) | 2.97769189 |
| 56 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.97523098 |
| 57 | axon extension involved in axon guidance (GO:0048846) | 2.97523098 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 2.96549791 |
| 59 | fibrinolysis (GO:0042730) | 2.93906821 |
| 60 | epoxygenase P450 pathway (GO:0019373) | 2.91789938 |
| 61 | desmosome organization (GO:0002934) | 2.89073239 |
| 62 | phospholipid homeostasis (GO:0055091) | 2.88600107 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 2.85041477 |
| 64 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.85006468 |
| 65 | fatty acid oxidation (GO:0019395) | 2.84285062 |
| 66 | cardiac myofibril assembly (GO:0055003) | 2.82990471 |
| 67 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.81544130 |
| 68 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.80881797 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 2.79530995 |
| 70 | reverse cholesterol transport (GO:0043691) | 2.78445097 |
| 71 | hemidesmosome assembly (GO:0031581) | 2.76145011 |
| 72 | lipid oxidation (GO:0034440) | 2.76011526 |
| 73 | positive regulation of fatty acid oxidation (GO:0046321) | 2.75605530 |
| 74 | regulation of establishment of planar polarity (GO:0090175) | 2.73877347 |
| 75 | fatty acid catabolic process (GO:0009062) | 2.72492922 |
| 76 | negative regulation of protein activation cascade (GO:2000258) | 2.72174586 |
| 77 | apoptotic cell clearance (GO:0043277) | 2.71756217 |
| 78 | embryonic camera-type eye development (GO:0031076) | 2.70728373 |
| 79 | fatty acid transmembrane transport (GO:1902001) | 2.69745405 |
| 80 | ethanol oxidation (GO:0006069) | 2.69218950 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.69136451 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 2.68383136 |
| 83 | glomerular basement membrane development (GO:0032836) | 2.67898952 |
| 84 | negative regulation of lipase activity (GO:0060192) | 2.67693985 |
| 85 | aromatic amino acid family metabolic process (GO:0009072) | 2.65961012 |
| 86 | basement membrane organization (GO:0071711) | 2.64971011 |
| 87 | monocarboxylic acid catabolic process (GO:0072329) | 2.64098577 |
| 88 | epithelial cell-cell adhesion (GO:0090136) | 2.62847678 |
| 89 | non-canonical Wnt signaling pathway (GO:0035567) | 2.62671046 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 2.62252197 |
| 91 | carnitine shuttle (GO:0006853) | 2.59911883 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 2.59003096 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.58735152 |
| 94 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.58529648 |
| 95 | glycine metabolic process (GO:0006544) | 2.58055701 |
| 96 | complement activation, classical pathway (GO:0006958) | 2.57850760 |
| 97 | fatty acid homeostasis (GO:0055089) | 2.57427344 |
| 98 | hippo signaling (GO:0035329) | 2.57148027 |
| 99 | cholesterol homeostasis (GO:0042632) | 2.57035910 |
| 100 | glutamate metabolic process (GO:0006536) | 2.56887796 |
| 101 | cochlea morphogenesis (GO:0090103) | 2.56552296 |
| 102 | regulation of cardioblast differentiation (GO:0051890) | 2.56462385 |
| 103 | establishment of apical/basal cell polarity (GO:0035089) | 2.55854226 |
| 104 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.55523863 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 2.54864579 |
| 106 | organic acid catabolic process (GO:0016054) | 2.54864579 |
| 107 | tyrosine metabolic process (GO:0006570) | 2.54561896 |
| 108 | biotin metabolic process (GO:0006768) | 2.53615407 |
| 109 | sterol homeostasis (GO:0055092) | 2.52467693 |
| 110 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.52165608 |
| 111 | polarized epithelial cell differentiation (GO:0030859) | 2.51409482 |
| 112 | hormone catabolic process (GO:0042447) | 2.50719010 |
| 113 | regulation of triglyceride metabolic process (GO:0090207) | 2.50459595 |
| 114 | very long-chain fatty acid metabolic process (GO:0000038) | 2.50427514 |
| 115 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.50389551 |
| 116 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.50151055 |
| 117 | imidazole-containing compound metabolic process (GO:0052803) | 2.50073010 |
| 118 | response to mercury ion (GO:0046689) | 2.49369243 |
| 119 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.49144843 |
| 120 | extracellular matrix assembly (GO:0085029) | 2.49026186 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 2.48399325 |
| 122 | protein heterotrimerization (GO:0070208) | 2.48170196 |
| 123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.47851455 |
| 124 | extracellular fibril organization (GO:0043206) | 2.47159924 |
| 125 | myelination in peripheral nervous system (GO:0022011) | 2.46546827 |
| 126 | peripheral nervous system axon ensheathment (GO:0032292) | 2.46546827 |
| 127 | complement activation (GO:0006956) | 2.46376492 |
| 128 | plasma lipoprotein particle remodeling (GO:0034369) | 2.46147636 |
| 129 | macromolecular complex remodeling (GO:0034367) | 2.46147636 |
| 130 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.45446110 |
| 131 | negative regulation of protein localization to cell surface (GO:2000009) | 2.38227716 |
| 132 | myofibril assembly (GO:0030239) | 2.36732003 |
| 133 | establishment of tissue polarity (GO:0007164) | 2.35484453 |
| 134 | establishment of planar polarity (GO:0001736) | 2.35484453 |
| 135 | lung-associated mesenchyme development (GO:0060484) | 2.35259378 |
| 136 | embryonic foregut morphogenesis (GO:0048617) | 2.34925511 |
| 137 | establishment of monopolar cell polarity (GO:0061162) | 2.33426659 |
| 138 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.33426659 |
| 139 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.31910473 |
| 140 | outer ear morphogenesis (GO:0042473) | 2.30682717 |
| 141 | lateral sprouting from an epithelium (GO:0060601) | 2.29874975 |
| 142 | plasma membrane repair (GO:0001778) | 2.29057868 |
| 143 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28226208 |
| 144 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.27560185 |
| 145 | camera-type eye morphogenesis (GO:0048593) | 2.27451556 |
| 146 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.24626972 |
| 147 | positive regulation of catenin import into nucleus (GO:0035413) | 2.24539933 |
| 148 | anterior/posterior axis specification, embryo (GO:0008595) | 2.24110443 |
| 149 | collagen metabolic process (GO:0032963) | 2.23211305 |
| 150 | endothelial cell morphogenesis (GO:0001886) | 2.22870217 |
| 151 | negative regulation of cartilage development (GO:0061037) | 2.21185876 |
| 152 | chondrocyte proliferation (GO:0035988) | 2.19874570 |
| 153 | glomerular visceral epithelial cell development (GO:0072015) | 2.18747322 |
| 154 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.18542786 |
| 155 | metanephric mesenchyme development (GO:0072075) | 2.15758116 |
| 156 | adherens junction assembly (GO:0034333) | 2.15485262 |
| 157 | organ induction (GO:0001759) | 2.14715612 |
| 158 | actomyosin structure organization (GO:0031032) | 2.14712036 |
| 159 | negative regulation of catenin import into nucleus (GO:0035414) | 2.13592788 |
| 160 | apical protein localization (GO:0045176) | 2.13108975 |
| 161 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.12684318 |
| 162 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.12684318 |
| 163 | skin morphogenesis (GO:0043589) | 2.12228022 |
| 164 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.11855130 |
| 165 | regulation of hippo signaling (GO:0035330) | 2.11728592 |
| 166 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.11660489 |
| 167 | neuromuscular junction development (GO:0007528) | 2.10632532 |
| 168 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.10226333 |
| 169 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.09213813 |
| 170 | dorsal/ventral axis specification (GO:0009950) | 2.08897476 |
| 171 | axon extension (GO:0048675) | 2.06691519 |
| 172 | regulation of catenin import into nucleus (GO:0035412) | 2.06208282 |
| 173 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.05951375 |
| 174 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.05416728 |
| 175 | postsynaptic membrane organization (GO:0001941) | 2.05314238 |
| 176 | semaphorin-plexin signaling pathway (GO:0071526) | 2.04979081 |
| 177 | collagen catabolic process (GO:0030574) | 2.04700614 |
| 178 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.04464770 |
| 179 | sarcomere organization (GO:0045214) | 2.03907772 |
| 180 | response to follicle-stimulating hormone (GO:0032354) | 2.03843972 |
| 181 | gap junction assembly (GO:0016264) | 2.03135987 |
| 182 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.03082417 |
| 183 | atrioventricular valve morphogenesis (GO:0003181) | 2.02758305 |
| 184 | actin-myosin filament sliding (GO:0033275) | 2.02174961 |
| 185 | muscle filament sliding (GO:0030049) | 2.02174961 |
| 186 | regulation of axon guidance (GO:1902667) | 2.02140267 |
| 187 | glomerular epithelial cell development (GO:0072310) | 2.02107305 |
| 188 | regulation of mesenchymal cell proliferation (GO:0010464) | 2.01199116 |
| 189 | protein localization to cell surface (GO:0034394) | 2.00754117 |
| 190 | cell migration involved in sprouting angiogenesis (GO:0002042) | 1.99999374 |
| 191 | actin-mediated cell contraction (GO:0070252) | 1.99903560 |
| 192 | regulation of transforming growth factor beta2 production (GO:0032909) | 1.99084323 |
| 193 | regulation of gene silencing by RNA (GO:0060966) | 1.98131127 |
| 194 | regulation of posttranscriptional gene silencing (GO:0060147) | 1.98131127 |
| 195 | regulation of gene silencing by miRNA (GO:0060964) | 1.98131127 |
| 196 | multicellular organismal metabolic process (GO:0044236) | 1.96894991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.38152225 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57611262 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.20475040 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.09193016 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.08440975 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.90233658 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.26248431 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.97824111 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.90103065 |
| 10 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.80160908 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.74827052 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.50448312 |
| 13 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.43013243 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.30368977 |
| 15 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.24912989 |
| 16 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.24912989 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.24912989 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04953809 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01734146 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94518063 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.91391808 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88207326 |
| 23 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88122236 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85317340 |
| 25 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.82451778 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.75157996 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69753615 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67310837 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.64154754 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.59903366 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.59903366 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59738448 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.59534319 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59499114 |
| 35 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54697091 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.53885277 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.50685218 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47990010 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45625733 |
| 40 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42268600 |
| 41 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.41614994 |
| 42 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.41614994 |
| 43 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39447148 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37237653 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37101003 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36211562 |
| 47 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35766657 |
| 48 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35007804 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34506186 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30755462 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30179672 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27129125 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26218184 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25720656 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25460486 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23362493 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23362341 |
| 58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.22978128 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20231768 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19822231 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19635708 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16893102 |
| 63 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.16862667 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16486240 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16043752 |
| 66 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.15719702 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15613435 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14453722 |
| 69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14124564 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12696967 |
| 71 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12681987 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12228290 |
| 73 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.11449152 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11049030 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10389136 |
| 76 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08608665 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.08310701 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07510414 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07328405 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06662555 |
| 81 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06517274 |
| 82 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05636288 |
| 83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05242332 |
| 84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.04960600 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04816057 |
| 86 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04563567 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04375749 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04349044 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03677561 |
| 90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03198482 |
| 91 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02926202 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02441246 |
| 93 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02379958 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01861751 |
| 95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01673362 |
| 96 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01571957 |
| 97 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01387159 |
| 98 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01316903 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00925784 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00826261 |
| 101 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00721074 |
| 102 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99960893 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99511317 |
| 104 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.99456311 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98293303 |
| 106 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.98052200 |
| 107 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97477821 |
| 108 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97262737 |
| 109 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97006603 |
| 110 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.96263059 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95861298 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95761886 |
| 113 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95749348 |
| 114 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.95505597 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95460681 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95460681 |
| 117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95400018 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94540449 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94142115 |
| 120 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.94057977 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93967327 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93954260 |
| 123 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93813067 |
| 124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93792906 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93770400 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92921823 |
| 127 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92678450 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92462472 |
| 129 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92420880 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92388808 |
| 131 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91893888 |
| 132 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91722318 |
| 133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90774479 |
| 134 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90252581 |
| 135 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89746332 |
| 136 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89491260 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88689474 |
| 138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88561761 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88006803 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87766119 |
| 141 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86657116 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85707869 |
| 143 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.84957104 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84902631 |
| 145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83502310 |
| 146 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.81038076 |
| 147 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80849423 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80722986 |
| 149 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80333903 |
| 150 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80048157 |
| 151 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.78603758 |
| 152 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.78379671 |
| 153 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77648626 |
| 154 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77222815 |
| 155 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.76915374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.97012847 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.90707821 |
| 3 | MP0005360_urolithiasis | 3.87731125 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.75626895 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.58872802 |
| 6 | MP0005365_abnormal_bile_salt | 3.56381955 |
| 7 | MP0003252_abnormal_bile_duct | 3.22606564 |
| 8 | MP0005275_abnormal_skin_tensile | 2.77325671 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30457633 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.18843672 |
| 11 | MP0009384_cardiac_valve_regurgitation | 2.13742722 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.11001404 |
| 13 | MP0004272_abnormal_basement_membrane | 2.09545998 |
| 14 | MP0000566_synostosis | 1.90482146 |
| 15 | MP0010329_abnormal_lipoprotein_level | 1.87563663 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 1.83268798 |
| 17 | MP0005083_abnormal_biliary_tract | 1.77170559 |
| 18 | MP0009840_abnormal_foam_cell | 1.73922378 |
| 19 | MP0005503_abnormal_tendon_morphology | 1.73080879 |
| 20 | MP0005666_abnormal_adipose_tissue | 1.71683191 |
| 21 | MP0002254_reproductive_system_inflammat | 1.70008311 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.66916371 |
| 23 | MP0002060_abnormal_skin_morphology | 1.65362333 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.62759746 |
| 25 | MP0005670_abnormal_white_adipose | 1.61319561 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.53808179 |
| 27 | MP0003283_abnormal_digestive_organ | 1.53791738 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.48719550 |
| 29 | MP0002796_impaired_skin_barrier | 1.44273260 |
| 30 | MP0005023_abnormal_wound_healing | 1.43485798 |
| 31 | MP0000751_myopathy | 1.41450183 |
| 32 | MP0003937_abnormal_limbs/digits/tail_de | 1.41098442 |
| 33 | MP0009053_abnormal_anal_canal | 1.40554034 |
| 34 | MP0005623_abnormal_meninges_morphology | 1.38688398 |
| 35 | MP0005332_abnormal_amino_acid | 1.37968636 |
| 36 | MP0003279_aneurysm | 1.36861017 |
| 37 | MP0005330_cardiomyopathy | 1.36282831 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.34567809 |
| 39 | MP0002269_muscular_atrophy | 1.34149876 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.32802228 |
| 41 | MP0000579_abnormal_nail_morphology | 1.30422093 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.29836194 |
| 43 | MP0000049_abnormal_middle_ear | 1.28888124 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.27832843 |
| 45 | MP0000749_muscle_degeneration | 1.24528200 |
| 46 | MP0003122_maternal_imprinting | 1.23938523 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.22764764 |
| 48 | MP0005451_abnormal_body_composition | 1.21404983 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.21357449 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.20439685 |
| 51 | MP0005375_adipose_tissue_phenotype | 1.19256546 |
| 52 | MP0002697_abnormal_eye_size | 1.17625832 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.17523998 |
| 54 | MP0000609_abnormal_liver_physiology | 1.16423042 |
| 55 | MP0001661_extended_life_span | 1.14892037 |
| 56 | MP0003045_fibrosis | 1.14216990 |
| 57 | MP0004130_abnormal_muscle_cell | 1.13209254 |
| 58 | MP0002282_abnormal_trachea_morphology | 1.13128901 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.12150338 |
| 60 | MP0000467_abnormal_esophagus_morphology | 1.11359126 |
| 61 | MP0009250_abnormal_appendicular_skeleto | 1.10541595 |
| 62 | MP0002233_abnormal_nose_morphology | 1.10350709 |
| 63 | MP0000747_muscle_weakness | 1.09938961 |
| 64 | MP0004858_abnormal_nervous_system | 1.08602460 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.07099216 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.06851447 |
| 67 | MP0005508_abnormal_skeleton_morphology | 1.06442543 |
| 68 | MP0006054_spinal_hemorrhage | 1.04522495 |
| 69 | MP0000762_abnormal_tongue_morphology | 1.04217781 |
| 70 | MP0010630_abnormal_cardiac_muscle | 1.03194749 |
| 71 | MP0000733_abnormal_muscle_development | 1.02754471 |
| 72 | MP0001849_ear_inflammation | 1.01932944 |
| 73 | MP0003195_calcinosis | 1.01286949 |
| 74 | MP0000750_abnormal_muscle_regeneration | 1.01277349 |
| 75 | MP0000778_abnormal_nervous_system | 1.00087480 |
| 76 | MP0000534_abnormal_ureter_morphology | 0.99995997 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 0.99685401 |
| 78 | MP0002108_abnormal_muscle_morphology | 0.99138909 |
| 79 | MP0003136_yellow_coat_color | 0.99059181 |
| 80 | MP0003119_abnormal_digestive_system | 0.98927911 |
| 81 | MP0001243_abnormal_dermal_layer | 0.98441989 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.98125685 |
| 83 | MP0001958_emphysema | 0.97964839 |
| 84 | MP0003755_abnormal_palate_morphology | 0.97869836 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.96834375 |
| 86 | MP0003868_abnormal_feces_composition | 0.96620752 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95562150 |
| 88 | MP0005369_muscle_phenotype | 0.95425252 |
| 89 | MP0003935_abnormal_craniofacial_develop | 0.94141198 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.94010208 |
| 91 | MP0004233_abnormal_muscle_weight | 0.93708453 |
| 92 | MP0002116_abnormal_craniofacial_bone | 0.93335280 |
| 93 | MP0003385_abnormal_body_wall | 0.92799451 |
| 94 | MP0004133_heterotaxia | 0.92475131 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.92135084 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.91696767 |
| 97 | MP0002168_other_aberrant_phenotype | 0.91684367 |
| 98 | MP0001984_abnormal_olfaction | 0.91642009 |
| 99 | MP0000432_abnormal_head_morphology | 0.90423357 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.89111273 |
| 101 | MP0005171_absent_coat_pigmentation | 0.89030703 |
| 102 | MP0005409_darkened_coat_color | 0.88946379 |
| 103 | MP0001293_anophthalmia | 0.88588717 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.86433067 |
| 105 | MP0004145_abnormal_muscle_electrophysio | 0.86040275 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.83685015 |
| 107 | MP0002938_white_spotting | 0.83555230 |
| 108 | MP0000647_abnormal_sebaceous_gland | 0.82909989 |
| 109 | MP0002092_abnormal_eye_morphology | 0.82707393 |
| 110 | MP0001177_atelectasis | 0.81114788 |
| 111 | MP0002111_abnormal_tail_morphology | 0.80087376 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.79750769 |
| 113 | MP0002971_abnormal_brown_adipose | 0.79574515 |
| 114 | MP0002106_abnormal_muscle_physiology | 0.79479896 |
| 115 | MP0003941_abnormal_skin_development | 0.78779282 |
| 116 | MP0003115_abnormal_respiratory_system | 0.78667682 |
| 117 | MP0003091_abnormal_cell_migration | 0.78665396 |
| 118 | MP0003011_delayed_dark_adaptation | 0.75881508 |
| 119 | MP0002128_abnormal_blood_circulation | 0.75313353 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.75230018 |
| 121 | MP0004036_abnormal_muscle_relaxation | 0.75206563 |
| 122 | MP0002972_abnormal_cardiac_muscle | 0.74754008 |
| 123 | MP0003861_abnormal_nervous_system | 0.74372068 |
| 124 | MP0002114_abnormal_axial_skeleton | 0.74107501 |
| 125 | MP0002932_abnormal_joint_morphology | 0.74049756 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.73024696 |
| 127 | MP0006138_congestive_heart_failure | 0.72755198 |
| 128 | MP0000428_abnormal_craniofacial_morphol | 0.71455617 |
| 129 | MP0000383_abnormal_hair_follicle | 0.70372631 |
| 130 | MP0001544_abnormal_cardiovascular_syste | 0.70313801 |
| 131 | MP0005385_cardiovascular_system_phenoty | 0.70313801 |
| 132 | MP0009703_decreased_birth_body | 0.70198764 |
| 133 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70150849 |
| 134 | MP0000462_abnormal_digestive_system | 0.70016632 |
| 135 | MP0010030_abnormal_orbit_morphology | 0.69754784 |
| 136 | MP0009672_abnormal_birth_weight | 0.69745039 |
| 137 | MP0002084_abnormal_developmental_patter | 0.69476863 |
| 138 | MP0005501_abnormal_skin_physiology | 0.69196970 |
| 139 | MP0003890_abnormal_embryonic-extraembry | 0.68963526 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.68707215 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.68306990 |
| 142 | MP0004215_abnormal_myocardial_fiber | 0.68151221 |
| 143 | MP0002896_abnormal_bone_mineralization | 0.68101037 |
| 144 | MP0002249_abnormal_larynx_morphology | 0.67806030 |
| 145 | MP0000598_abnormal_liver_morphology | 0.66434288 |
| 146 | MP0003942_abnormal_urinary_system | 0.66239279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.01632689 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.50431289 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.21939794 |
| 4 | Complement deficiency (HP:0004431) | 4.14200191 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 3.99090750 |
| 6 | Xanthomatosis (HP:0000991) | 3.94779667 |
| 7 | Increased connective tissue (HP:0009025) | 3.89292803 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.54661612 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 3.40814194 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.38046515 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.27598859 |
| 12 | Shallow orbits (HP:0000586) | 3.24389868 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.22535129 |
| 14 | Atrophic scars (HP:0001075) | 3.14573825 |
| 15 | Abnormality of complement system (HP:0005339) | 3.08197473 |
| 16 | Neonatal short-limb short stature (HP:0008921) | 3.06364280 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.05512287 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 3.03548156 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 2.99901375 |
| 20 | Broad metatarsal (HP:0001783) | 2.88428055 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 2.83435972 |
| 22 | Mitral valve prolapse (HP:0001634) | 2.80728982 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 2.75005235 |
| 24 | Aortic dissection (HP:0002647) | 2.68731253 |
| 25 | Hypolipoproteinemia (HP:0010981) | 2.63485605 |
| 26 | Ketosis (HP:0001946) | 2.61589794 |
| 27 | Hyperammonemia (HP:0001987) | 2.60970486 |
| 28 | Cervical subluxation (HP:0003308) | 2.56788632 |
| 29 | Peritonitis (HP:0002586) | 2.55855619 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 2.55250083 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.54028255 |
| 32 | Muscle fiber splitting (HP:0003555) | 2.49893530 |
| 33 | Epidermoid cyst (HP:0200040) | 2.49683272 |
| 34 | Disproportionate tall stature (HP:0001519) | 2.49617705 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.46760307 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46760307 |
| 37 | Ankle contracture (HP:0006466) | 2.45384923 |
| 38 | Skin nodule (HP:0200036) | 2.41458853 |
| 39 | Abnormality of dentin (HP:0010299) | 2.40213957 |
| 40 | Hyperglycinuria (HP:0003108) | 2.37344907 |
| 41 | Bronchomalacia (HP:0002780) | 2.36706062 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.36459048 |
| 43 | Hyperglycinemia (HP:0002154) | 2.36292555 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33486127 |
| 45 | Exercise-induced muscle cramps (HP:0003710) | 2.30676892 |
| 46 | Sudden death (HP:0001699) | 2.29996996 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.29630987 |
| 48 | Difficulty running (HP:0009046) | 2.29449216 |
| 49 | Limited hip movement (HP:0008800) | 2.25695897 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.25672316 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.24981940 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.24944594 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.24088453 |
| 54 | Joint hemorrhage (HP:0005261) | 2.23856922 |
| 55 | Myocardial infarction (HP:0001658) | 2.23839725 |
| 56 | Achilles tendon contracture (HP:0001771) | 2.23572337 |
| 57 | Bladder diverticulum (HP:0000015) | 2.23255548 |
| 58 | Blue sclerae (HP:0000592) | 2.23013538 |
| 59 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20644434 |
| 60 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20644434 |
| 61 | Aplasia involving bones of the extremities (HP:0009825) | 2.20644434 |
| 62 | Aneurysm (HP:0002617) | 2.19580123 |
| 63 | Turricephaly (HP:0000262) | 2.19271042 |
| 64 | Hypoplastic ischia (HP:0003175) | 2.19194027 |
| 65 | Aortic aneurysm (HP:0004942) | 2.17935720 |
| 66 | Myoglobinuria (HP:0002913) | 2.17434102 |
| 67 | Vascular tortuosity (HP:0004948) | 2.13841342 |
| 68 | Glomerulonephritis (HP:0000099) | 2.13333503 |
| 69 | Retinal atrophy (HP:0001105) | 2.12628572 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.12326167 |
| 71 | Camptodactyly of toe (HP:0001836) | 2.12075667 |
| 72 | Ulnar bowing (HP:0003031) | 2.12072514 |
| 73 | Esophageal varix (HP:0002040) | 2.11976488 |
| 74 | Abnormality of the ischium (HP:0003174) | 2.10913172 |
| 75 | Infantile muscular hypotonia (HP:0008947) | 2.10437649 |
| 76 | Round ear (HP:0100830) | 2.09021810 |
| 77 | Wide anterior fontanel (HP:0000260) | 2.08415998 |
| 78 | Soft skin (HP:0000977) | 2.07893529 |
| 79 | Fragile skin (HP:0001030) | 2.07186231 |
| 80 | Thin ribs (HP:0000883) | 2.06998026 |
| 81 | Biconcave vertebral bodies (HP:0004586) | 2.06654489 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.06485856 |
| 83 | Scapular winging (HP:0003691) | 2.06367931 |
| 84 | Bowel diverticulosis (HP:0005222) | 2.04467287 |
| 85 | Wormian bones (HP:0002645) | 2.01998345 |
| 86 | Ketoacidosis (HP:0001993) | 2.01260939 |
| 87 | Coronal craniosynostosis (HP:0004440) | 1.99263400 |
| 88 | Breech presentation (HP:0001623) | 1.99096662 |
| 89 | Vascular calcification (HP:0004934) | 1.97838507 |
| 90 | Abnormal cartilage morphology (HP:0002763) | 1.97425333 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96972575 |
| 92 | Lymphangioma (HP:0100764) | 1.95486223 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 1.95299010 |
| 94 | Spinal rigidity (HP:0003306) | 1.93052285 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 1.92561125 |
| 96 | Vitreoretinal degeneration (HP:0000655) | 1.92309454 |
| 97 | Mitral stenosis (HP:0001718) | 1.90744113 |
| 98 | Renovascular hypertension (HP:0100817) | 1.90396394 |
| 99 | Exercise-induced myalgia (HP:0003738) | 1.90348350 |
| 100 | Alopecia of scalp (HP:0002293) | 1.89110548 |
| 101 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88799089 |
| 102 | Pseudobulbar signs (HP:0002200) | 1.88503009 |
| 103 | Abnormality of the calcaneus (HP:0008364) | 1.87396317 |
| 104 | Pterygium (HP:0001059) | 1.86997767 |
| 105 | Hip contracture (HP:0003273) | 1.85593562 |
| 106 | Arnold-Chiari malformation (HP:0002308) | 1.85584508 |
| 107 | Neoplasm of the heart (HP:0100544) | 1.85163587 |
| 108 | Difficulty climbing stairs (HP:0003551) | 1.85024535 |
| 109 | Hyperextensible skin (HP:0000974) | 1.84700950 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83939136 |
| 111 | Alacrima (HP:0000522) | 1.83590306 |
| 112 | Arterial tortuosity (HP:0005116) | 1.83438822 |
| 113 | Cutaneous finger syndactyly (HP:0010554) | 1.82905474 |
| 114 | Abnormal delivery (HP:0001787) | 1.82187832 |
| 115 | Hypoplasia of the iris (HP:0007676) | 1.80787953 |
| 116 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80450274 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.80247251 |
| 118 | Abnormality of methionine metabolism (HP:0010901) | 1.79537028 |
| 119 | Calcaneovalgus deformity (HP:0001848) | 1.78934797 |
| 120 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78302124 |
| 121 | Natal tooth (HP:0000695) | 1.77793711 |
| 122 | Cutaneous syndactyly (HP:0012725) | 1.77460387 |
| 123 | Joint laxity (HP:0001388) | 1.76275164 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76125075 |
| 125 | Broad long bones (HP:0005622) | 1.75654183 |
| 126 | Advanced eruption of teeth (HP:0006288) | 1.74929841 |
| 127 | Overgrowth (HP:0001548) | 1.74708958 |
| 128 | Fat malabsorption (HP:0002630) | 1.74050656 |
| 129 | Flat cornea (HP:0007720) | 1.73572703 |
| 130 | EMG: myopathic abnormalities (HP:0003458) | 1.72796169 |
| 131 | Mitral regurgitation (HP:0001653) | 1.72106350 |
| 132 | Focal segmental glomerulosclerosis (HP:0000097) | 1.70948377 |
| 133 | Deformed tarsal bones (HP:0008119) | 1.69139538 |
| 134 | Amyloidosis (HP:0011034) | 1.68768611 |
| 135 | Abnormality of the calf musculature (HP:0001430) | 1.68577875 |
| 136 | Ectopia lentis (HP:0001083) | 1.68490771 |
| 137 | Back pain (HP:0003418) | 1.68389205 |
| 138 | Abnormality of the aortic arch (HP:0012303) | 1.67485004 |
| 139 | Calf muscle hypertrophy (HP:0008981) | 1.67290033 |
| 140 | Preaxial foot polydactyly (HP:0001841) | 1.62616905 |
| 141 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.61439386 |
| 142 | Genu recurvatum (HP:0002816) | 1.60051791 |
| 143 | Broad phalanx (HP:0006009) | 1.59552410 |
| 144 | Short 4th metacarpal (HP:0010044) | 1.59538440 |
| 145 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.59538440 |
| 146 | Popliteal pterygium (HP:0009756) | 1.59074343 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.56270786 |
| 148 | Tracheal stenosis (HP:0002777) | 1.55334960 |
| 149 | Osteoarthritis (HP:0002758) | 1.54450179 |
| 150 | Choanal stenosis (HP:0000452) | 1.53724070 |
| 151 | Distal arthrogryposis (HP:0005684) | 1.53529591 |
| 152 | Wrist flexion contracture (HP:0001239) | 1.53517588 |
| 153 | Hyperacusis (HP:0010780) | 1.52819577 |
| 154 | Renal duplication (HP:0000075) | 1.52457154 |
| 155 | Rhizomelia (HP:0008905) | 1.51728492 |
| 156 | Decreased lacrimation (HP:0000633) | 1.48182500 |
| 157 | Bell-shaped thorax (HP:0001591) | 1.48086156 |
| 158 | Partial duplication of the phalanx of hand (HP:0009999) | 1.47528710 |
| 159 | Vertebral arch anomaly (HP:0008438) | 1.46849788 |
| 160 | Broad finger (HP:0001500) | 1.46495907 |
| 161 | Broad phalanges of the hand (HP:0009768) | 1.46228546 |
| 162 | Hammertoe (HP:0001765) | 1.44878440 |
| 163 | Tracheomalacia (HP:0002779) | 1.44248702 |
| 164 | Morphological abnormality of the middle ear (HP:0008609) | 1.44111409 |
| 165 | Partial duplication of thumb phalanx (HP:0009944) | 1.43677020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.29304286 |
| 2 | SIK1 | 2.90735443 |
| 3 | ERN1 | 2.89378031 |
| 4 | DDR2 | 2.81889290 |
| 5 | TGFBR2 | 2.65445727 |
| 6 | PKN2 | 2.50185858 |
| 7 | LATS1 | 2.40340923 |
| 8 | MAP3K6 | 2.35479691 |
| 9 | BCKDK | 2.24558611 |
| 10 | TTN | 2.23576030 |
| 11 | EPHB1 | 2.10870114 |
| 12 | EEF2K | 2.07609410 |
| 13 | FGFR4 | 1.99551463 |
| 14 | PDGFRA | 1.95920326 |
| 15 | MAPK15 | 1.84547420 |
| 16 | ICK | 1.78941153 |
| 17 | MARK1 | 1.77964293 |
| 18 | TYRO3 | 1.76264676 |
| 19 | MET | 1.74610067 |
| 20 | MAP2K3 | 1.73530534 |
| 21 | OBSCN | 1.72255392 |
| 22 | MAPKAPK3 | 1.71155475 |
| 23 | PBK | 1.60693572 |
| 24 | EPHA2 | 1.57782715 |
| 25 | MAP3K3 | 1.56146396 |
| 26 | LATS2 | 1.52476542 |
| 27 | FER | 1.41589160 |
| 28 | PTK6 | 1.40559528 |
| 29 | PAK4 | 1.40543693 |
| 30 | PTK2 | 1.39898870 |
| 31 | TNIK | 1.34706485 |
| 32 | CDK12 | 1.32858314 |
| 33 | MTOR | 1.24437460 |
| 34 | RIPK1 | 1.22141100 |
| 35 | LMTK2 | 1.20360212 |
| 36 | PAK3 | 1.15793567 |
| 37 | PRKD3 | 1.15053615 |
| 38 | DMPK | 1.12214516 |
| 39 | PDK2 | 1.11928077 |
| 40 | PAK2 | 1.09996574 |
| 41 | PHKG2 | 1.08551299 |
| 42 | PHKG1 | 1.08551299 |
| 43 | EPHA3 | 1.08028479 |
| 44 | TTK | 1.04685577 |
| 45 | EPHB2 | 1.04657738 |
| 46 | NTRK3 | 1.03136412 |
| 47 | MAP2K4 | 1.02092213 |
| 48 | MUSK | 0.99916427 |
| 49 | DYRK1B | 0.99371159 |
| 50 | BCR | 0.97225599 |
| 51 | MAP3K7 | 0.95553609 |
| 52 | MAP3K10 | 0.93611752 |
| 53 | RPS6KB2 | 0.92829087 |
| 54 | ERBB2 | 0.92577733 |
| 55 | TRPM7 | 0.90999717 |
| 56 | RET | 0.90952639 |
| 57 | PDGFRB | 0.89862583 |
| 58 | FGFR2 | 0.87669113 |
| 59 | CASK | 0.86362753 |
| 60 | CAMK1D | 0.84604587 |
| 61 | DYRK2 | 0.84556491 |
| 62 | CSK | 0.83867492 |
| 63 | MAP3K2 | 0.83521113 |
| 64 | STK39 | 0.82930341 |
| 65 | PKN1 | 0.81707565 |
| 66 | PRKAA2 | 0.80764856 |
| 67 | PINK1 | 0.80643359 |
| 68 | PDK4 | 0.78068549 |
| 69 | PDK3 | 0.78068549 |
| 70 | PRKD1 | 0.77394502 |
| 71 | AKT3 | 0.76883278 |
| 72 | NEK2 | 0.76818806 |
| 73 | RPS6KA2 | 0.76480798 |
| 74 | STK38 | 0.76365242 |
| 75 | BMX | 0.75894322 |
| 76 | MAPK12 | 0.75557443 |
| 77 | MAPK7 | 0.75218141 |
| 78 | IRAK1 | 0.74832042 |
| 79 | STK38L | 0.73920514 |
| 80 | NEK1 | 0.73061101 |
| 81 | NEK9 | 0.71704917 |
| 82 | ERBB4 | 0.71000881 |
| 83 | CAMK1G | 0.70580248 |
| 84 | MAP2K1 | 0.70153627 |
| 85 | NTRK1 | 0.70049923 |
| 86 | WNK1 | 0.70022161 |
| 87 | GSK3A | 0.68644200 |
| 88 | EPHA4 | 0.68533479 |
| 89 | FLT3 | 0.67178979 |
| 90 | NLK | 0.66984236 |
| 91 | PIK3CA | 0.66581034 |
| 92 | PNCK | 0.65938354 |
| 93 | INSRR | 0.64552977 |
| 94 | NTRK2 | 0.64481815 |
| 95 | CDK3 | 0.61039538 |
| 96 | MST1R | 0.60418418 |
| 97 | PRKD2 | 0.60399695 |
| 98 | ROCK1 | 0.59818089 |
| 99 | LIMK1 | 0.59178080 |
| 100 | PIK3CG | 0.59140657 |
| 101 | PAK6 | 0.59048956 |
| 102 | MAP2K2 | 0.58924589 |
| 103 | STK3 | 0.58574654 |
| 104 | SGK223 | 0.58186247 |
| 105 | SGK494 | 0.58186247 |
| 106 | AKT2 | 0.57617143 |
| 107 | MAPK11 | 0.56656786 |
| 108 | BRSK2 | 0.56569011 |
| 109 | ILK | 0.55198163 |
| 110 | ROCK2 | 0.53857766 |
| 111 | MAPKAPK5 | 0.50295615 |
| 112 | CAMK2G | 0.49639585 |
| 113 | MAP3K4 | 0.47488493 |
| 114 | MYLK | 0.46748750 |
| 115 | TIE1 | 0.45164564 |
| 116 | IGF1R | 0.44535032 |
| 117 | JAK1 | 0.44299395 |
| 118 | WNK4 | 0.44239070 |
| 119 | CAMK2D | 0.44231912 |
| 120 | CDC42BPA | 0.44039139 |
| 121 | MARK2 | 0.43356025 |
| 122 | CSF1R | 0.43325167 |
| 123 | FGFR1 | 0.41536721 |
| 124 | MAP2K6 | 0.41328290 |
| 125 | KSR2 | 0.40778450 |
| 126 | BMPR1B | 0.40150761 |
| 127 | JAK2 | 0.39796640 |
| 128 | PRKAA1 | 0.39620867 |
| 129 | CAMK4 | 0.39511692 |
| 130 | NME1 | 0.37730634 |
| 131 | LRRK2 | 0.37638601 |
| 132 | BRSK1 | 0.37280806 |
| 133 | TESK1 | 0.37250100 |
| 134 | CSNK1G1 | 0.34985907 |
| 135 | MAPK10 | 0.34412722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33897081 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.22170101 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86581501 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61299580 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53128530 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46395191 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45487937 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28841831 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28438837 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.27905859 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23196531 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.20035661 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18099707 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12788153 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99155004 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92261663 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83078435 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70310522 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67092212 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61417693 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57222383 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56462950 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55895300 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.53304524 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.49883339 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49591916 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45264857 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42414617 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37294483 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34271654 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.32581169 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27359048 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.25635896 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25251323 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23556140 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.22409816 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20211792 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18219154 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16433723 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15252503 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11591852 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06142492 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04246116 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03630289 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.01977465 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00129336 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99400186 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98795599 |
| 49 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.95949894 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95314019 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.93425086 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89097663 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.87834283 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86744479 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83671228 |
| 56 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83530645 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82663093 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.79542881 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.78650026 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77879451 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77855113 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77733526 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76719088 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76687808 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75179414 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74726181 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74118117 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72087541 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71709273 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.71308631 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71302654 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70645515 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69691351 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69174526 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68986648 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68209719 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67221397 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67021051 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65971700 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65136715 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64987372 |
| 82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64909224 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.64824038 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64132983 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63602392 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63135442 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.61721615 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59383550 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59320889 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.56868969 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56086460 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55871213 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55725752 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54997050 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54682814 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54218009 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54199197 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53847932 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53221463 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51791815 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.51324516 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49906455 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48463239 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48256503 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46644300 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45669111 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.45299798 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44962606 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42531884 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42184577 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41377840 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40409503 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39814259 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39296458 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39062111 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38842878 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38033176 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35247154 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34175428 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29299845 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26064088 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25852022 |
| 123 | Axon guidance_Homo sapiens_hsa04360 | 0.25587267 |
| 124 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24505816 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24432976 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22066051 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21231292 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21160185 |

